Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients
A. Mékinian(Sorbonne Université), David Saadoun(Sorbonne Université), Matthieu Resche‐Rigon(Inserm), M. Ruivard(University of Clermont Auvergne), Cloé Comarmond(Centre National de la Recherche Scientifique), Isabelle Koné‐Paut(Université Paris-Saclay), P. Cacoub(Sorbonne Université), C. Landron(Université de Poitiers), Alessandra Soriano, J. Constans(Centre Hospitalier Universitaire de Bordeaux), Bertrand Lioger(Université de Tours), Karim Sacré(Sorbonne Université), P. Jégo(CIC Rennes), Laurent Alric, Christian Lavigne(Université d'Angers), Martin Michaud(Centre Hospitalier Universitaire de Toulouse), Tiphaine Goulenok(Hôpital Beaujon), Carlo Salvarani(University of Modena and Reggio Emilia), Jacques Éric Gottenberg(Inserm), Olivier Fain(Assistance Publique – Hôpitaux de Paris), Matthieu Cabon(Inserm), Florian Busato(Centre Hospitalier de Bigorre), Robin Dhôte(Assistance Publique – Hôpitaux de Paris), F. Gaches
Cited by 84
Related Papers
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
Proinflammatory Cytokines, Aging, and Age-Related Diseases
|Journal of the American Medical Directors Association|2013|1.1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
|New England Journal of Medicine|2009|857
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777